Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$2,605,554.00
Jan 6, 2012
197819
197819
New clinical tools for high-resolution imaging of the ear
$500,000.00
Jan 1, 2012
For-profit organization
802649
802649
The project entails developing, testing, and conducting clinical studies of the CIMVA clinical decision support software with the objective of securing regulatory clearance from the U.S.
$165,000.00
Nov 1, 2011
Post-doctoral training in meta-analysis and clinical trials methodology related to fructose, carbohydrate quality, and risk of chronic disease.
$35,000.00
Oct 26, 2011
199835
199835
Acquisition of a clinical nutritional biochemist
$867,000.00
Oct 18, 2011
For-profit organization
509298
509298
Pre-Clinical Development and Human Clinical Trial of an MRI compatible medical device for treatment of prostate cancer, with long-term objectives of accelerating market entry into the US and Europe.
$339,058.00
Oct 1, 2011
Advancing gel dosimetry for clinical radiation therapy
$187,071.00
Oct 1, 2011
The Art of Waiting: Evaluation of an interactive media experience in a children's hospital clinic waiting space
$478,008.00
Oct 1, 2011
Defining the clinical and immune causes of disproportionately high HIV levels in semen.
$340,314.00
Oct 1, 2011
Abnormal Activation of Thymocytes High-Mobility Group Box Protein (TOX) in Cutaneous T Cell Lymphomas: Pathogenic Significance and Clinical Applications
$150,000.00
Oct 1, 2011
Identification of novel FFA1 and GPR120 ligands and their use in elucidating the pharmacology, function, and clinical utility of these receptors in the treatment of obesity and diabetes.